Characterization of Phase I and Glucuronide Phase II Metabolites of 17 Mycotoxins Using Liquid Chromatography—High-Resolution Mass Spectrometry

Routine mycotoxin biomonitoring methods do not include many mycotoxin phase I and phase II metabolites, which may significantly underestimate mycotoxin exposure especially for heavily metabolized mycotoxins. Additional research efforts are also needed to measure metabolites in vivo after exposure an...

Full description

Bibliographic Details
Main Authors: Irina Slobodchikova, Reajean Sivakumar, Md Samiur Rahman, Dajana Vuckovic
Format: Article
Language:English
Published: MDPI AG 2019-07-01
Series:Toxins
Subjects:
Online Access:https://www.mdpi.com/2072-6651/11/8/433
_version_ 1811279119389818880
author Irina Slobodchikova
Reajean Sivakumar
Md Samiur Rahman
Dajana Vuckovic
author_facet Irina Slobodchikova
Reajean Sivakumar
Md Samiur Rahman
Dajana Vuckovic
author_sort Irina Slobodchikova
collection DOAJ
description Routine mycotoxin biomonitoring methods do not include many mycotoxin phase I and phase II metabolites, which may significantly underestimate mycotoxin exposure especially for heavily metabolized mycotoxins. Additional research efforts are also needed to measure metabolites in vivo after exposure and to establish which mycotoxin metabolites should be prioritized for the inclusion during large-scale biomonitoring efforts. The objective of this study was to perform human in vitro microsomal incubations of 17 mycotoxins and systematically characterize all resulting metabolites using liquid chromatography−high-resolution mass spectrometry (LC-HRMS). The results obtained were then used to build a comprehensive LC-MS library and expand a validated 17-mycotoxin method for exposure monitoring to screening of additional 188 metabolites, including 100 metabolites reported for the first time. The final method represents one of the most comprehensive LC-HRMS methods for mycotoxin biomonitoring or metabolism/fate studies.
first_indexed 2024-04-13T00:49:02Z
format Article
id doaj.art-b28f63085543428c84d4a87d11843ba7
institution Directory Open Access Journal
issn 2072-6651
language English
last_indexed 2024-04-13T00:49:02Z
publishDate 2019-07-01
publisher MDPI AG
record_format Article
series Toxins
spelling doaj.art-b28f63085543428c84d4a87d11843ba72022-12-22T03:09:55ZengMDPI AGToxins2072-66512019-07-0111843310.3390/toxins11080433toxins11080433Characterization of Phase I and Glucuronide Phase II Metabolites of 17 Mycotoxins Using Liquid Chromatography—High-Resolution Mass SpectrometryIrina Slobodchikova0Reajean Sivakumar1Md Samiur Rahman2Dajana Vuckovic3Department of Chemistry and Biochemistry, Concordia University, 7141 Sherbrooke Street West, Montreal, QC H4B 1R6, CanadaDepartment of Chemistry and Biochemistry, Concordia University, 7141 Sherbrooke Street West, Montreal, QC H4B 1R6, CanadaDepartment of Chemistry and Biochemistry, Concordia University, 7141 Sherbrooke Street West, Montreal, QC H4B 1R6, CanadaDepartment of Chemistry and Biochemistry, Concordia University, 7141 Sherbrooke Street West, Montreal, QC H4B 1R6, CanadaRoutine mycotoxin biomonitoring methods do not include many mycotoxin phase I and phase II metabolites, which may significantly underestimate mycotoxin exposure especially for heavily metabolized mycotoxins. Additional research efforts are also needed to measure metabolites in vivo after exposure and to establish which mycotoxin metabolites should be prioritized for the inclusion during large-scale biomonitoring efforts. The objective of this study was to perform human in vitro microsomal incubations of 17 mycotoxins and systematically characterize all resulting metabolites using liquid chromatography−high-resolution mass spectrometry (LC-HRMS). The results obtained were then used to build a comprehensive LC-MS library and expand a validated 17-mycotoxin method for exposure monitoring to screening of additional 188 metabolites, including 100 metabolites reported for the first time. The final method represents one of the most comprehensive LC-HRMS methods for mycotoxin biomonitoring or metabolism/fate studies.https://www.mdpi.com/2072-6651/11/8/433mycotoxinsmetabolismhigh-resolution mass spectrometry (HRMS)microsomal incubationglucuronidationhumanbiomonitoring
spellingShingle Irina Slobodchikova
Reajean Sivakumar
Md Samiur Rahman
Dajana Vuckovic
Characterization of Phase I and Glucuronide Phase II Metabolites of 17 Mycotoxins Using Liquid Chromatography—High-Resolution Mass Spectrometry
Toxins
mycotoxins
metabolism
high-resolution mass spectrometry (HRMS)
microsomal incubation
glucuronidation
human
biomonitoring
title Characterization of Phase I and Glucuronide Phase II Metabolites of 17 Mycotoxins Using Liquid Chromatography—High-Resolution Mass Spectrometry
title_full Characterization of Phase I and Glucuronide Phase II Metabolites of 17 Mycotoxins Using Liquid Chromatography—High-Resolution Mass Spectrometry
title_fullStr Characterization of Phase I and Glucuronide Phase II Metabolites of 17 Mycotoxins Using Liquid Chromatography—High-Resolution Mass Spectrometry
title_full_unstemmed Characterization of Phase I and Glucuronide Phase II Metabolites of 17 Mycotoxins Using Liquid Chromatography—High-Resolution Mass Spectrometry
title_short Characterization of Phase I and Glucuronide Phase II Metabolites of 17 Mycotoxins Using Liquid Chromatography—High-Resolution Mass Spectrometry
title_sort characterization of phase i and glucuronide phase ii metabolites of 17 mycotoxins using liquid chromatography high resolution mass spectrometry
topic mycotoxins
metabolism
high-resolution mass spectrometry (HRMS)
microsomal incubation
glucuronidation
human
biomonitoring
url https://www.mdpi.com/2072-6651/11/8/433
work_keys_str_mv AT irinaslobodchikova characterizationofphaseiandglucuronidephaseiimetabolitesof17mycotoxinsusingliquidchromatographyhighresolutionmassspectrometry
AT reajeansivakumar characterizationofphaseiandglucuronidephaseiimetabolitesof17mycotoxinsusingliquidchromatographyhighresolutionmassspectrometry
AT mdsamiurrahman characterizationofphaseiandglucuronidephaseiimetabolitesof17mycotoxinsusingliquidchromatographyhighresolutionmassspectrometry
AT dajanavuckovic characterizationofphaseiandglucuronidephaseiimetabolitesof17mycotoxinsusingliquidchromatographyhighresolutionmassspectrometry